Cargando…
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
BACKGROUND: Studies showed that axillary lymph node dissection can be safely omitted in presence of positive sentinel lymph node(s) in breast cancer patients treated with breast conserving therapy. Since the outcome of the sentinel lymph node biopsy has no clinical consequence, the value of the proc...
Autores principales: | van Roozendaal, L. M., Vane, M. L. G., van Dalen, T., van der Hage, J. A., Strobbe, L. J. A., Boersma, L. J., Linn, S. C., Lobbes, M. B. I., Poortmans, P. M. P., Tjan-Heijnen, V. C. G., Van de Vijver, K. K. B. T., de Vries, J., Westenberg, A. H., Kessels, A. G. H., de Wilt, J. H. W., Smidt, M. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494134/ https://www.ncbi.nlm.nih.gov/pubmed/28668073 http://dx.doi.org/10.1186/s12885-017-3443-x |
Ejemplares similares
-
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
por: van Roozendaal, L. M., et al.
Publicado: (2015) -
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, S., et al.
Publicado: (2015) -
Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer
por: van Roozendaal, Lori M., et al.
Publicado: (2015) -
Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction
por: Samiei, S., et al.
Publicado: (2019) -
Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?
por: Habraken, V., et al.
Publicado: (2016)